Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG
Tài liệu tham khảo
Crespo J, Iglesias-García J, Hinojosa del Val J, Ampuero Herrojo J, Pérez-Cuadrado Martínez E. Afectación en aparato digestivo por COVID 19. Ref:7128/2020
Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032
2020, Protecting health care workers during the COVID-19 coronavirus outbreak-lessons from Taiwan's SARS response, Clin Infect Dis
Li, 2020, Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2), Science, 368, 489, 10.1126/science.abb3221
2020, COVID-19: protecting health-care workers, Lancet, 395, 922, 10.1016/S0140-6736(20)30644-9
Flaxman, 2020, Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries, Imperial College London
https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD013574/full/es?contentLanguage=es.
Remuzzi, 2020, COVID-19 and Italy: what next?, Lancet, 10.1016/S0140-6736(20)30627-9
Terry, 2020
Ohannessian, 2020, Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action, JMIR Public Health Surveill, 6, e18810, 10.2196/18810
Serper, 2020, Telemedicine in liver disease and beyond: can the COVID-19 crisis lead to action?, Hepatology, 10.1002/hep.31276
Rubin, 2020, Clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary, Gastroenterology, 10.1053/j.gastro.2020.04.012
Xiao, 2020, Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology, 10.1053/j.gastro.2020.02.055
Wu, 2020, Prolonged presence of SARS-CoV-2 viral RNA in faecal samples, Lancet Gastroenterol Hepatol, 5, 434, 10.1016/S2468-1253(20)30083-2
Norsa, 2020, Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy, Gastroenterology, 10.1053/j.gastro.2020.03.062
Ferreira, 2020, 1st interview COVID-19 ECCO taskforce, J Crohn's Colitis
Current Data Secure-IBD Database. https://covidibd.org/current-data/.
BSG expanded consensus advice for the management of IBD during the COVID-19 pandemic. The British Society of Gastroenterology. https://www.bsg.org.uk/covid-19-advice/bsg-advice-for-management-of-inflammatory-bowel-diseases-during-the-covid-19-pandemic/. Published March 30, 2020 [accessed 31.03.20].
Rubin, 2020, AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary, Gastroenterology, 10.1053/j.gastro.2020.04.012
Brake, 2020, Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19), J Clin Med, 9, 10.3390/jcm9030841
Zingone, 2020, Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak, Lancet Gastroenterol Hepatol, 10.1016/S2468-1253(20)30085-6
Mazza, 2020, A fatal case of COVID-19 pneumonia occurring in apatient with severe acute ulcerative colitis., Gut, 10.1136/gutjnl-2020-321183
Lamb, 2019, British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults, Gut, 68, s1, 10.1136/gutjnl-2019-318484
Kemp, 2018, Second N-ECCO consensus statements on the european nursing roles in caring for patients with crohn's disease or ulcerative colitis, J Crohns Colitis, 12, 760, 10.1093/ecco-jcc/jjy020
Aguas, 2016, Telemedicine in inflammatory bowel disease: opportunity ahead, Inflamm Bowel Dis, 22, E4, 10.1097/MIB.0000000000000676
Calvet, 2014, Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units, J Crohns Colitis, 8, 240, 10.1016/j.crohns.2013.10.010
Van Assche, 2012, Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial, Gut, 61, 229, 10.1136/gutjnl-2011-300755
Lin, 2020, Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection, Gut, 10.1136/gutjnl-2020-321013
Chiu, 2020, Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements), Gut, 10.1136/gutjnl-2020-321185
Han, 2020, Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures, Gastrointest Endosc, 10.1016/j.gie.2020.03.3855
Zhang, 2020, Suggestions for infection prevention and control in digestive endoscopy during current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China, Endoscopy, 52, 312, 10.1055/a-1128-4313
Cheung, 2020, Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong Cohort and systematic review and meta-analysis, Gastroenterology
Sociedad Española de Patología Digestiva, Asociación Española de Gastroenterología, 2020, Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18), Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic – European Society of Gastrointestinal Endoscopy (ESGE) [Internet]. Available from: https://www.esge.com/esge-and-esgena-position-statement-on-gastrointestinal-endoscopy-and-the-covid-19-pandemic/ [cited 13.04.20].
Repici, 2020, Coronavirus (COVID-19) outbreak: what the department of endoscopy should know, Gastrointest Endosc, 10.1016/j.gie.2020.03.019
Beilenhoff, 2018, Endoscopy, 50, 1205, 10.1055/a-0759-1629
Zhang, 2020, Liver injury in COVID-19: management and challenges, Lancet Gastroenterol Hepatol, 10.1016/S2468-1253(20)30057-1
Liang, 2020, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, 21, 335, 10.1016/S1470-2045(20)30096-6
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5
D’Antiga, 2020, Coronaviruses and immunosuppressed patients. The facts during the third epidemic, Liver Transpl, 10.1002/lt.25756
2020
Organización Nacional de Trasplantes. 13/04/2020. REFERENCIA: BV-ES-20200122-8.